Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond One Year after Percutaneous Coronary Intervention: An Analysis from the Randomized Dual Antiplatelet Therapy Study

IMPORTANCE: Dual antiplatelet therapy after percutaneous coronary intervention (PCI) reduces ischemia at the expense of increased bleeding. OBJECTIVE: To develop a clinical decision tool to identify patients expected to derive benefit vs. harm from continuing thienopyridine beyond one year after PCI...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA
Asıl Yazarlar: Yeh, Robert W., Secemsky, Eric A., Kereiakes, Dean J., Normand, Sharon-Lise T., Gershlick, Anthony H., Cohen, David J., Spertus, John A., Steg, Philippe Gabriel, Cutlip, Donald E., Rinaldi, Michael J., Camenzind, Edoardo, Wijns, William, Apruzzese, Patricia K., Song, Yang, Massaro, Joseph M., Mauri, Laura
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408574/
https://ncbi.nlm.nih.gov/pubmed/27022822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2016.3775
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller